Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 10 studies | 29% ± 12% | |
endothelial cell | 9 studies | 32% ± 18% | |
endothelial cell of lymphatic vessel | 8 studies | 25% ± 6% | |
endothelial cell of artery | 3 studies | 28% ± 16% | |
epithelial cell | 3 studies | 35% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 29% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3597.72 | 2612 / 2642 | 98% | 32.42 | 693 / 705 |
uterus | 98% | 2178.54 | 166 / 170 | 95% | 40.95 | 435 / 459 |
lung | 100% | 3236.18 | 576 / 578 | 91% | 25.78 | 1056 / 1155 |
thymus | 95% | 1293.89 | 620 / 653 | 94% | 31.12 | 569 / 605 |
ovary | 91% | 1134.91 | 163 / 180 | 94% | 40.91 | 403 / 430 |
stomach | 93% | 1392.21 | 334 / 359 | 88% | 20.48 | 253 / 286 |
kidney | 100% | 2333.58 | 89 / 89 | 72% | 39.46 | 652 / 901 |
intestine | 83% | 1450.31 | 803 / 966 | 89% | 21.18 | 468 / 527 |
bladder | 81% | 3038.29 | 17 / 21 | 90% | 25.19 | 452 / 504 |
adrenal gland | 95% | 1582.39 | 244 / 258 | 75% | 107.26 | 173 / 230 |
pancreas | 72% | 662.50 | 237 / 328 | 97% | 42.07 | 173 / 178 |
breast | 72% | 746.97 | 331 / 459 | 97% | 45.10 | 1084 / 1118 |
prostate | 98% | 3349.36 | 240 / 245 | 69% | 11.48 | 346 / 502 |
esophagus | 72% | 2293.45 | 1037 / 1445 | 93% | 35.76 | 171 / 183 |
skin | 98% | 2844.30 | 1770 / 1809 | 63% | 12.61 | 298 / 472 |
spleen | 100% | 2253.52 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.34 | 1 / 1 |
heart | 99% | 2817.33 | 855 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 44.50 | 44 / 45 |
blood vessel | 98% | 2888.19 | 1305 / 1335 | 0% | 0 | 0 / 0 |
adipose | 74% | 800.21 | 885 / 1204 | 0% | 0 | 0 / 0 |
liver | 24% | 234.63 | 54 / 226 | 35% | 6.66 | 144 / 406 |
eye | 0% | 0 | 0 / 0 | 48% | 5.66 | 38 / 80 |
lymph node | 0% | 0 | 0 / 0 | 34% | 4.61 | 10 / 29 |
muscle | 11% | 103.62 | 89 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.59 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0038007 | Biological process | netrin-activated signaling pathway |
GO_0001525 | Biological process | angiogenesis |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0033564 | Biological process | anterior/posterior axon guidance |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0045121 | Cellular component | membrane raft |
GO_0005886 | Cellular component | plasma membrane |
GO_0005042 | Molecular function | netrin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | UNC5B |
Protein name | Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1) |
Synonyms | UNC5H2 P53RDL1 UNQ1883/PRO4326 |
Description | FUNCTION: Receptor for netrin required for axon guidance. Mediates axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding. Axon repulsion in growth cones may be caused by its association with DCC that may trigger signaling for repulsion (By similarity). Functions as a netrin receptor that negatively regulates vascular branching during angiogenesis. Mediates retraction of tip cell filopodia on endothelial growth cones in response to netrin (By similarity). It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand . Mediates apoptosis by activating DAPK1. In the absence of NTN1, activates DAPK1 by reducing its autoinhibitory phosphorylation at Ser-308 thereby increasing its catalytic activity (By similarity). . |
Accessions | ENST00000373192.4 [Q8IZJ1-2] Q8IZJ1 ENST00000335350.10 [Q8IZJ1-1] |